Organon

World Contraception Day - With 48% of pregnancies being unintentional, let’s talk about contraception options

Retrieved on: 
Monday, September 26, 2022

This means too few women and girls do not know enough about the options available.

Key Points: 
  • This means too few women and girls do not know enough about the options available.
  • We are offering a podcast to help women and young women to learn about contraception options available and how to discuss the matter with a physician.
  • For World Contraception Day, the SOGC also came up with a specific set of solutions gathered in one location: www.sogc.org/contraception .
  • On this September 26th, World Contraception Day is an opportunity to recognize that millions of women and girls need more education, better availability for contraception options, and better cooperation from men.

Organon Canada reinforces the need to raise awareness and access for contraception methods with nearly half of pregnancies unplanned

Retrieved on: 
Monday, September 26, 2022

Organon is proud to support the Society of Obstetricians and Gynaecologists of Canada (SOGC) to reinforce the importance of education and awareness in reducing unplanned pregnancies in Canada through roundtable discussions.

Key Points: 
  • Organon is proud to support the Society of Obstetricians and Gynaecologists of Canada (SOGC) to reinforce the importance of education and awareness in reducing unplanned pregnancies in Canada through roundtable discussions.
  • Nearly half of all pregnancies in Canada are unintended1 and UIP is a public health and reproductive health concern worldwide2.
  • A recent survey* funded by Organon Canada showed 48 per cent of 18-40 years old women in Canada would be financially impacted by an unintended pregnancy.
  • "Women who experience unplanned pregnancies are at high risk for many health factors, which can have overwhelming and negative impacts.

With 48% of pregnancies being unintentional, let’s talk about contraception options

Retrieved on: 
Saturday, September 24, 2022

This means too few women and girls do not know enough about the options available.

Key Points: 
  • This means too few women and girls do not know enough about the options available.
  • We are offering a podcast to help women and young women to learn about contraception options available and how to discuss the matter with a physician.
  • For World Contraception Day, the SOGC also came up with a specific set of solutions gathered in one location: www.sogc.org/contraception .
  • On this September 26th, World Contraception Day is an opportunity to recognize that millions of women and girls need more education, better availability for contraception options, and better cooperation from men.

DeepIntent's Chris Paquette Named CEO of the Year in 2022 PM360 Trailblazer Awards

Retrieved on: 
Friday, September 23, 2022

NEW YORK, Sept. 23, 2022 /PRNewswire/ --PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named Chris Paquette a CEO of the Year in its annual Trailblazer Awards.

Key Points: 
  • NEW YORK, Sept. 23, 2022 /PRNewswire/ --PM360, a publication for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries, recently named Chris Paquette a CEO of the Year in its annual Trailblazer Awards.
  • That year, CEO Chris Paquette was named to the PM360 ELITE list in the Entrepreneur category and selected as the publication's 2020 Trailblazer Vanguard Award winner.
  • "I founded DeepIntent on the idea that technology can measurably improve the lives of patients," said Chris Paquette, CEO, DeepIntent.
  • Since 2009, the PM360 Trailblazer Awards have recognized outstanding achievement and innovation in healthcare marketing.

PM360 Magazine Announces Winners of 2022 Trailblazer Awards

Retrieved on: 
Friday, September 23, 2022

NEW YORK, Sept. 23, 2022 /PRNewswire/ -- PM360, a leading life sciences marketing industry trade publication, announced the winners of their 14th annual Trailblazer Awards during an event held at Gotham Hall in New York City on Thursday, September 22, 2022. The awards recognize outstanding companies, CEOs, products, marketers, brand managers, and cutting-edge initiatives within the pharmaceutical, biotech, medical device, and diagnostics industries. In total, 72 winners were named across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives.

Key Points: 
  • NEW YORK, Sept. 23, 2022 /PRNewswire/ -- PM360, a leading life sciences marketing industry trade publication, announced the winners of their 14th annual Trailblazer Awards during an event held at Gotham Hall in New York City on Thursday, September 22, 2022.
  • The awards recognize outstanding companies, CEOs, products, marketers, brand managers, and cutting-edge initiatives within the pharmaceutical, biotech, medical device, and diagnostics industries.
  • Each of the winners were judged and selected by the PM360 Editorial Advisory Board, a cross section of experts from across the industry.
  • PM360 will publish profiles of this year's Trailblazer winners in its October issue and on its website.

Cambrian BioPharma Appoints Ruth Thieroff-Ekerdt as Executive Vice President of Clinical Development

Retrieved on: 
Wednesday, September 21, 2022

NEW YORK, Sept. 21, 2022 /PRNewswire/ -- Cambrian BioPharma , a multi-asset longevity biotech, today announces the appointment of Ruth Thieroff-Ekerdt, M.D., as Executive Vice President of Clinical Development.

Key Points: 
  • NEW YORK, Sept. 21, 2022 /PRNewswire/ -- Cambrian BioPharma , a multi-asset longevity biotech, today announces the appointment of Ruth Thieroff-Ekerdt, M.D., as Executive Vice President of Clinical Development.
  • "Adding Ruth to the Cambrian team is an important step towards ensuring our work to increase healthspan while creating life-changing medicines for patients suffering from diseases today," said James Peyer, CEO, Cambrian BioPharma.
  • "Her background and vast knowledge of clinical development will allow Cambrian to thoughtfully advance our wide array of programs into human trials."
  • In her role, Dr. Thieroff-Ekerdt will be responsible for a broad range of development activities including the continuation and creation of clinical development and strategy.

Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer

Retrieved on: 
Monday, September 19, 2022

DUBLIN, Sept. 19, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced it has appointed Lisa French as Executive Vice President and Chief Commercial Officer, effective October 1, 2022.

Key Points: 
  • DUBLIN, Sept. 19, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced it has appointed Lisa French as Executive Vice President and Chief Commercial Officer, effective October 1, 2022.
  • Ms. French will serve on the Executive Committee and succeeds Hugh O'Neill, who departed Mallinckrodt as of September 16, 2022.
  • Ms. French most recently built and led the U.S. Women's Health Commercial team for Organon & Co. following its spin-off from Merck.
  • Siggi Olafsson, President and Chief Executive Officer, said, "I am delighted to welcome Lisa to Mallinckrodt as our new Chief Commercial Officer and a member of our Executive Committee.

Daré Bioscience to Participate in Two Upcoming Conferences

Retrieved on: 
Thursday, September 15, 2022

SAN DIEGO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Dar Bioscience, Inc. (NASDAQ: DARE ), a leader in womens health innovation, today announced that Sabrina Martucci Johnson, the companys President and CEO, will participate in two upcoming conferences.

Key Points: 
  • SAN DIEGO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Dar Bioscience, Inc. (NASDAQ: DARE ), a leader in womens health innovation, today announced that Sabrina Martucci Johnson, the companys President and CEO, will participate in two upcoming conferences.
  • Dar Bioscience is a biopharmaceutical company committed to advancing innovative products for womens health.
  • The information Dar posts on its investor relations website or through social media channels may be deemed to be material information.
  • Investors on behalf of Dar Bioscience, Inc.:

Cambrian BioPharma Announces its Scientific Advisory Board led by Two Veteran R&D Executives

Retrieved on: 
Wednesday, September 14, 2022

NEW YORK, Sept. 14, 2022 /PRNewswire/ -- Cambrian BioPharma , a multi-asset longevity biotech, today announces its Scientific Advisory Board (SAB) and appointment of C. David Nicholson, PhD and Frank S. Walsh, PhD to lead.

Key Points: 
  • NEW YORK, Sept. 14, 2022 /PRNewswire/ -- Cambrian BioPharma , a multi-asset longevity biotech, today announces its Scientific Advisory Board (SAB) and appointment of C. David Nicholson, PhD and Frank S. Walsh, PhD to lead.
  • SAB reports are shared with individual pipeline companies for consideration in project strategy and planning and are also shared with the Cambrian BioPharma Board of Directors.
  • Moving forward Cambrian may add further SAB members or ad-hoc advisors as its pipeline grows and matures.
  • "Cambrian BioPharma is honored to have two highly experienced R&D executives to assist with our pursuit of expanding healthspan in the 21st century," said Brenton L. Saunders, Cambrian BioPharma Board of Directors.

Organon and Flat6Labs Announce Winners of MENA Region's First Digital-Health FemTech Accelerator

Retrieved on: 
Tuesday, September 13, 2022

CAIRO, Sept. 13, 2022  /PRNewswire/ -- Omgyno founded by Doreen Toutikian and Elisabeth Milini in Greece and Lebanon, Siira founded by Sandra Salame in Lebanon, and Maternally founded by Yasmin El Mouallem in the UAE were crowned the winners of the MENA region's first digital-health FemTech Accelerator Program. Launched in October 2021 during Expo 2020 by partners Organon and Flat6Labs to address unmet women's healthcare needs, the winners were announced after the program's ten finalists from across Egypt, Lebanon, UAE, Bahrain, Morocco, and Jordan pitched their ideas to a panel of judges and an audience of prospective investors.  

Key Points: 
  • Omgyno, the start-up that won first place, is a FemTech platform redesigning the gynecological experience.
  • Dina El Shenoufy, Chief Investment Officer at Flat6Labs, commented, "At Flat6Labs, we have been delighted to participate in and support this female empowerment initiative.
  • Flat6Labs is the MENA region's leading seed and early-stage venture capital firm, currently running the most renowned startup programs in the region.
  • Launched and headquartered in Cairo since 2011, Flat6Labs has multiple offices across the region with ongoing plans to expand into other emerging markets.